Skip to main content
. 2019 Dec 19;12:2715–2723. doi: 10.2147/DMSO.S231321

Table 3.

Comparison of miRNAs Levels in NAFLD Patients with Control and Comparison Between NAFLD Subgroups

miRNA-122 (M ± SD) miRNA-34a (M ± SD) miRNA-99a (M ± SD)
NAFLD group (n=210) 4.15 ±2.94 2.96 ±1.62 0.82 ±0.27
Control group (n=90) 0.82 ±0.27 1.53±0.98 1.04 ±0.52
NAFLD versus controls p<0.001 p<0.001 p<0.05
Simple steatosis (n=124) 3.41 ±1.98 2.89 ±1.75 0.95 ±0.14
NASH (n=86) 5.74 ±2.16 4.12 ±0.48 0.67 ±0.12
Simple steatosis versus NASH p<0.005 p<0.001 p<0.001

Notes: P value is significant if <0.05 and p value is non-significant if >0.05.

Abbreviations: NAFLD, non alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis.